PUBLISHER: TechNavio | PRODUCT CODE: 1908814
PUBLISHER: TechNavio | PRODUCT CODE: 1908814
The global open-angle glaucoma therapeutics market is forecasted to grow by USD 3071.8 mn during 2025-2030, accelerating at a CAGR of 6.9% during the forecast period. The report on the global open-angle glaucoma therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by promising pipeline and recent approvals for glaucoma therapeutics, increasing demand for combination drugs for glaucoma treatment, rising geriatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2026 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 6.6% |
| CAGR | 6.9% |
| Incremental Value | $3071.8 mn |
Technavio's global open-angle glaucoma therapeutics market is segmented as below:
By Product
By Channel
By Route Of Administration
Geography
This study identifies the development of biologics for glaucoma treatment as one of the prime reasons driving the global open-angle glaucoma therapeutics market growth during the next few years. Also, growing collaboration and alliance among companies and growing awareness about glaucoma will lead to sizable demand in the market.
The report on the global open-angle glaucoma therapeutics market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global open-angle glaucoma therapeutics market vendors that include AbbVie Inc., Alcon Inc., Bausch Health Companies Inc., Hikma Pharmaceuticals Plc, Merck and Co. Inc., Nicox S.A., Novartis AG, Otsuka Pharmaceutical Co Ltd., Pfizer Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Ltd.. Also, the global open-angle glaucoma therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.